TUMOR-INFILTRATING LYMPHOCYTES IN GLIOBLASTOMA ARE ASSOCIATED WITH NF1, TP53, AND RB1 MUTATIONS AND THE MESENCHYMAL TRANSCRIPTIONAL SUBTYPE

被引:0
|
作者
Rutledge, William C. [1 ]
Kong, Jun
Gao, Jingjing
Gutman, David A.
Cooper, Lee A.
Chisolm, Candace [1 ]
Scarpace, Lisa [2 ]
Mikkelsen, Tom [2 ]
Saltz, Joel H.
Moreno, Carlos S.
Brat, Daniel J. [1 ]
机构
[1] Emory Univ, Sch Med, Atlanta, GA USA
[2] Henry Ford Hlth Syst, Detroit, MI USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:41 / 41
页数:1
相关论文
共 50 条
  • [11] The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds
    Duan, Xiaohui
    Cai, Yi
    He, Tingting
    Shi, Xiaoliang
    Zhao, Juan
    Zhang, Hui
    Shen, Yao
    Zhang, Hongjian
    Zhang, Heng
    Duan, Wenbin
    Jiang, Bo
    Mao, Xianhai
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (04) : 1786 - 1796
  • [12] Tumor-Infiltrating Lymphocytes in Glioblastoma Are Associated with Specific Genomic Alterations and Related to Transcriptional Class
    Rutledge, W. Caleb
    Kong, Jun
    Gao, Jingjing
    Gutman, David A.
    Cooper, Lee A. D.
    Appin, Christina
    Park, Yuna
    Scarpace, Lisa
    Mikkelsen, Tom
    Cohen, Mark L.
    Aldape, Kenneth D.
    McLendon, Roger E.
    Lehman, Norman L.
    Miller, C. Ryan
    Schniederjan, Matthew J.
    Brennan, Cameron W.
    Saltz, Joel H.
    Moreno, Carlos S.
    Brat, Daniel J.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (18) : 4951 - 4960
  • [13] Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish
    Luo, Juanjuan
    Liu, Pei
    Lu, Chunjiao
    Bian, Wanping
    Su, Dongsheng
    Zhu, Chenchen
    Xie, Shaolin
    Pan, Yihang
    Li, Ningning
    Cui, Wei
    Pei, De-Sheng
    Yang, Xiaojun
    [J]. BRAIN, 2021, 144 : 615 - 635
  • [14] Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish
    Luo, Juanjuan
    Liu, Pei
    Lu, Chunjiao
    Bian, Wanping
    Su, Dongsheng
    Zhu, Chenchen
    Xie, Shaolin
    Pan, Yihang
    Li, Ningning
    Cui, Wei
    Pei, De-Sheng
    Yang, Xiaojun
    [J]. BRAIN, 2021, 144 (02) : 615 - 635
  • [15] Notch signaling and Tp53/RB1 pathway in pulmonary neuroendocrine tumorigenesis
    Ito, Takaaki
    Matsuo, Akira
    Hassan, Wael Abdo
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 (02) : 213 - 219
  • [16] RB1 AND TP53 LOSS PROMOTES LINEAGE PLASTICITY IN PROSTATE CANCER
    不详
    [J]. CANCER DISCOVERY, 2017, 7 (03) : 244 - 244
  • [17] PHENOTYPIC-GENOTYPIC CORRELATION OF TP53 AND RB1 IN UROTHELIAL CARCINOMA
    Audenet, Francois
    Isharwal, Sumit
    Zheng, Xiaoyong
    Jordan, Emmet
    Iyer, Gopa
    Lee, Byron
    Cha, Eugene
    Donahue, Timothy
    Donat, Machele
    Herr, Harry
    Dalbagni, Guido
    Bochner, Bernard
    Berger, Michael
    Solit, David
    Al-Ahmadie, Hikmat
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E644 - E644
  • [18] Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
    Berghoff, Anna Sophie
    Kiesel, Barbara
    Widhalm, Georg
    Rajky, Orsolya
    Ricken, Gerda
    Woehrer, Adelheid
    Dieckmann, Karin
    Filipits, Martin
    Brandstetter, Anita
    Weller, Michael
    Kurscheid, Sebastian
    Hegi, Monika E.
    Zielinski, Christoph C.
    Marosi, Christine
    Hainfellner, Johannes A.
    Preusser, Matthias
    Wick, Wolfgang
    [J]. NEURO-ONCOLOGY, 2015, 17 (08) : 1064 - 1075
  • [19] Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors
    Merten, Larissa
    Agaimy, Abbas
    Moskalev, Evgeny A.
    Giedl, Johannes
    Kayser, Claudia
    Geddert, Helene
    Schaefer, Inga-Marie
    Cameron, Silke
    Werner, Martin
    Stroebel, Philip
    Hartmann, Arndt
    Haller, Florian
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 (06) : 718 - 726
  • [20] Concurrent somatic alterations of TP53 and RB1 in Chinese lung adenocarcinoma with or without EGFR mutations.
    Wang, Jun
    Chen, Gang
    Zhang, Bicheng
    Sun, Jianguo
    Liang, Jing
    Liu, Xiaolin
    Li, Yan
    Wang, Baocheng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)